Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
59 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to BioCardia, Inc.’s names, not what it holds today.
Patents granted
59
59 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 2 in 2024 and 3 in 2023
Applications published
66
1 of them in 2025
Names they are printed under
4
its own name, a former name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology6
Biotechnology1
Analysis of biological materials1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
BioCardia Inc. its own name
US, as the owner printed on each patent
53 publishedBioCardia, Inc. its own name
named as the applicant on its applications, in US
10 publishedCardo Medical, Inc. a former name
US, as the owner printed on each patent
2 publishedclickNsettle.com, Inc. a former name
US, as the owner printed on each patent
1 publishedNames not counted (2)
NAM CORP
Most of its patents print JP; this name counts in US. 3 granted and 1 published under it are not counted.
NAM CORP
Most of its patents print JP; this name counts in US. 0 granted and 3 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 27, 2025 | 12,311,127 | Radial and trans-endocardial delivery catheter | Medical technology | BioCardia Inc. |
| Jul 16, 2024 | 12,036,371 | Method of accessing the left atrium with a multi-directional steerable catheter | Medical technology | BioCardia Inc. |
| May 21, 2024 | 11,986,611 | Radial and trans-endocardial delivery catheter | Medical technology | BioCardia Inc. |
| Nov 28, 2023 | 11,828,757 | Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies | Analysis of biological materials | BioCardia Inc. |
| May 9, 2023 | 11,642,377 | Bone marrow derived neurokinin-1 receptor positive (NK1R+) mesenchymal stem cells for therapeutic applications | Biotechnology | BioCardia Inc. |
| Apr 4, 2023 | 11,617,859 | Multi-directional steerable catheter | Medical technology | BioCardia Inc. |
| Jun 14, 2022 | 11,357,463 | Target site selection, entry and update with automatic remote image annotation | Medical technology | BioCardia Inc. |
| Oct 12, 2021 | 11,141,568 | Multi-directional steerable catheter | Medical technology | BioCardia Inc. |
| Dec 29, 2020 | 10,874,831 | Devices and methods for accessing the vasculature of a patient | Medical technology | BioCardia Inc. |
| Sep 22, 2020 | 10,780,248 | Radial and trans-endocardial delivery catheter | Medical technology | BioCardia Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Mar 13, 2025 | 2025/0082903 | Method of Accessing A Vascular Site With A Multi-Directional Steerable Catheter | Medical technology | BioCardia Inc. |
| Mar 14, 2024 | 2024/0082310 | BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) MESENCHYMAL STEM CELLS FOR THERAPEUTIC APPLICATIONS | Biotechnology | BioCardia, Inc. |
| Nov 9, 2023 | 2023/0355652 | FETAL STROMAL CELL DERIVED EXOSOMES FOR TISSUE REPAIR | Pharmaceuticals | BioCardia, Inc. |
| Jul 27, 2023 | 2023/0233805 | Method of Accessing the Left Atrium with a Multi-Directional Steerable Catheter | Medical technology | BioCardia Inc. · patent 12,036,371 granted from it |
| Sep 29, 2022 | 2022/0305237 | RADIAL AND TRANS-ENDOCARDIAL DELIVERY CATHETER | Medical technology | BioCardia Inc. · patent 12,311,127 granted from it |
| Jun 2, 2022 | 2022/0168544 | Multi-Directional Steerable Catheter | Medical technology | BioCardia Inc. · patent 11,617,859 granted from it |
| Oct 14, 2021 | 2021/0315532 | TARGET SITE SELECTION, ENTRY AND UPDATE WITH AUTOMATIC REMOTE IMAGE ANNOTATION | Medical technology | BioCardia Inc. |
| Jun 3, 2021 | 2021/0164978 | METHODS OF MEASURING POTENTIAL FOR THERAPEUTIC POTENCY AND DEFINING DOSAGES FOR AUTOLOGOUS CELL THERAPIES | Analysis of biological materials | BioCardia Inc. · patent 11,828,757 granted from it |
| Dec 24, 2020 | 2020/0398029 | RADIAL AND TRANS-ENDOCARDIAL DELIVERY CATHETER | Medical technology | BioCardia Inc. · patent 11,986,611 granted from it |
| Apr 2, 2020 | 2020/0101113 | BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) PRECURSOR CELLS FOR THERAPEUTIC APPLICATIONS | Biotechnology | BioCardia, Inc. · patent 11,642,377 granted from it |
What it applied for, 2024 to 2025: Biotechnology 1 · Medical technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.